Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

12.30
Delayed Data
As of 12:31pm ET
 0.00 / 0.00%
Today’s Change
7.02
Today|||52-Week Range
13.65
+1.65%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close12.30
Today’s open12.35
Day’s range11.95 - 12.50
Volume225,784
Average volume (3 months)331,817
Market cap$713.5M
Dividend yield--
Data as of 12:31pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-98.80%
Earnings growth (this year)+40.59%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.82%
P/E ratioNM
Price/Sales249.31
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
ANIPANI Pharmaceuticals ...-3.05-4.84%
CRSPCRISPR Therapeutics ...-0.30-1.73%
MYOVMyovant Sciences Ltd-0.11-0.98%
RTRXRetrophin Inc+0.53+2.60%
Data as of 12:44pm ET, 02/22/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$2.6M
Annual profit (last year)-$132.4M
Net profit margin-5,170.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs